Sign in
4

Changes in Ownership

Moleculin Biotech, Inc. Filed Acc 0001437749-22-015536

CEO and President gave up 6,088 shares (to pay taxes)

  • CEO and President acquired 25,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
KLEMP WALTER V CEO and President 2022-06-16 Option exercise +25,000 217,401 D
KLEMP WALTER V CEO and President 2022-06-16 Shares withheld for taxes −6,088 $1.33 $8,097 211,313 D
Derivatives
KLEMP WALTER V CEO and President 2022-06-16 Option exercise · Restricted Stock Units −25,000 675,862 D
Loading xslF345X03/rdgdoc.xml…